US drug companies will negotiate prices of 10 drugs while continuing to challenge the processBMJ 2023; 383 doi: https://doi.org/10.1136/bmj.p2338 (Published 09 October 2023) Cite this as: BMJ 2023;383:p2338
- Janice Hopkins Tanne
- New York
US pharmaceutical companies have agreed to negotiate the prices of 10 drugs with the federal government.1 All are, however, continuing to sue the government, claiming that the negotiations violate several constitutional rights.
The drug industry sees price negotiations for patients on Medicare, the health insurance scheme for over 65s, as a foot in the door for further negotiations on drug prices, which are common elsewhere in the world. At least eight lawsuits have been filed against the government to try to stop them.2 The drugs are used by some of the …